Kobuk Therapeutics trademark application for pharmaceutical preparations
Summary
The USPTO received trademark application TM99107436 for 'KOBUK THERAPEUTICS' filed by Kobuk Therapeutics on March 27, 2025. The application covers pharmaceutical preparations and medicines in Nice Class 5 for the treatment of viral, metabolic, cardiovascular, oncological, neurological, and other disease categories. This is an Intent-to-Use application, indicating the applicant plans to use the mark in commerce.
What changed
The USPTO published Kobuk Therapeutics' Intent-to-Use trademark application for 'KOBUK THERAPEUTICS' covering pharmaceutical preparations and substances in Nice Class 5. The application was filed March 27, 2025, under registration number TM99107436. The goods description encompasses pharmaceutical preparations for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, and immune system diseases and disorders.
Trademark applicants or competitors in the pharmaceutical space should review the goods and services description for potential conflicts. The USPTO will examine the application and, if approved, publish it for opposition. Third parties will have an opportunity to oppose registration during the opposition period. No immediate compliance action is required from pharmaceutical companies, though trademark counsel should monitor for publication and potential opposition proceedings.
Archived snapshot
Apr 1, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
KOBUK THERAPEUTICS
Intent to Use TM99107436 Kind: intenttouse Mar 31, 2026
Abstract
Development of pharmaceutical preparations and medicines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Filing Date
2025-03-27
Named provisions
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.